Fibromyalgia & musculoskeletal pain

Testing a Personalized Approach to Chronic Low Back Pain: A Randomized Controlled Trial in Older Veterans

Arthritis Care Res (Hoboken)Published Randomised controlled trial

Authors' conclusion

We did not find confirmatory evidence that personalized care (ABC) was superior with respect to ODI.

Study context

Population
Veterans aged 65 to 89 with chronic low back pain, three Veterans Affairs (VA) medical centers12 months of follow-up
Participants
299 veterans
Comparison
Personalized care in Aging Back Clinics vs usual care
Primary endpoint
Change in the Oswestry Disability Index (ODI)
Follow-up
6 months
Methodological detailsmulticentre (three VA medical centers)
  • Multicentre (three VA medical centers)

Primary result

As reported in the abstract

Change in ODI
  • No significant group differences in Oswestry Disability Index (ODI) change
  • Intention-to-treat

Secondary outcomes

OutcomeABCUC
PROMIS-29 physical function scale, change · 12 months1.7 points−0.4 points
PROMIS Global physical health, change · 6 months1.3−1.2
PROMIS Global physical health, change · 12 months0.7−1.5
PROMIS Global mental health, change · 6 months0.2−2.3
Present and prior week average/worst pain · over 12 months · greater improvement with ABC
all P < 0.05
Falls · over 12 months · marginally fewer falls with ABC
P = 0.0527
  • PROMIS-29 physical function scale, change: greater improvement with ABC; all P < 0.05
  • PROMIS Global physical health, change: greater improvement with ABC; all P < 0.05
  • PROMIS Global physical health, change: greater improvement with ABC; all P < 0.05
  • PROMIS Global mental health, change: greater improvement with ABC; all P < 0.05

Original publication

Testing a Personalized Approach to Chronic Low Back Pain: A Randomized Controlled Trial in Older Veterans. Arthritis Care Res (Hoboken). Published 8 February 2026. doi:10.1002/acr.25671

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.